Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yen-Yang Chen

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Peerj|November 26, 2020
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenibYen-Yang Chen, Chih-Chi Wang, Yueh-Wei Liu, et al.
Cancer Diagnosis & Prognosis|March 4, 2025
Outcomes of Liposomal Irinotecan With 5-FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance StatusChieh-Ying Chang, Tai-Jan Chiu, Yen-Yang Chen, et al.
Anticancer Research|February 28, 2023
Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular CarcinomaJen-Yu Cheng, Bing-Shen Huang, Yen-Yang Chen, et al.
Journal of Cancer|July 9, 2016
Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of BladderMeng-Che Hsieh, Cheng-Hua Huang, Po-Hui Chiang, et al.
Cancer Management and Research|April 3, 2019
Evolution of the chemotherapeutic landscape and survival outcome in patients with metastatic pancreatic cancer: a four-institute cohort study in Taiwan, 2010-2016Wen-Chi Chou, Yen-Yang Chen, Chia-Yen Hung, et al.
BMC Cancer|November 8, 2022
Low-dose nivolumab in advanced hepatocellular carcinomaYen-Hao Chen, Chih-Chi Wang, Yen-Yang Chen, et al.
Cancers|November 25, 2023
Combined Serum ALBUMIN with Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Biliary Tract Cancer after Curative ResectionTai-Jan Chiu, Yueh-Wei Liu, Chee-Chien Yong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2016
Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapyMeng-Che Hsieh, Yu-Li Su, Po-Hui Chiang, et al.
Cancers|November 15, 2018
Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative ChemotherapyYu-Shin Hung, Jen-Shi Chen, Yen-Yang Chen, et al.
Urologic Oncology|August 10, 2015
The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapyMeng-Che Hsieh, Po-Hui Chiang, Kun-Ming Rau, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Peerj|November 26, 2020
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenibYen-Yang Chen, Chih-Chi Wang, Yueh-Wei Liu, et al.
Cancer Diagnosis & Prognosis|March 4, 2025
Outcomes of Liposomal Irinotecan With 5-FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance StatusChieh-Ying Chang, Tai-Jan Chiu, Yen-Yang Chen, et al.
Anticancer Research|February 28, 2023
Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular CarcinomaJen-Yu Cheng, Bing-Shen Huang, Yen-Yang Chen, et al.
Journal of Cancer|July 9, 2016
Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of BladderMeng-Che Hsieh, Cheng-Hua Huang, Po-Hui Chiang, et al.
Cancer Management and Research|April 3, 2019
Evolution of the chemotherapeutic landscape and survival outcome in patients with metastatic pancreatic cancer: a four-institute cohort study in Taiwan, 2010-2016Wen-Chi Chou, Yen-Yang Chen, Chia-Yen Hung, et al.
BMC Cancer|November 8, 2022
Low-dose nivolumab in advanced hepatocellular carcinomaYen-Hao Chen, Chih-Chi Wang, Yen-Yang Chen, et al.
Cancers|November 25, 2023
Combined Serum ALBUMIN with Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Biliary Tract Cancer after Curative ResectionTai-Jan Chiu, Yueh-Wei Liu, Chee-Chien Yong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2016
Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapyMeng-Che Hsieh, Yu-Li Su, Po-Hui Chiang, et al.
Cancers|November 15, 2018
Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative ChemotherapyYu-Shin Hung, Jen-Shi Chen, Yen-Yang Chen, et al.
Urologic Oncology|August 10, 2015
The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapyMeng-Che Hsieh, Po-Hui Chiang, Kun-Ming Rau, et al.
Pageof 10